» Articles » PMID: 22269477

Cannabinoid Signalling Regulates Inflammation and Energy Balance: the Importance of the Brain-gut Axis

Overview
Publisher Elsevier
Date 2012 Jan 25
PMID 22269477
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Energy balance is controlled by centres of the brain which receive important inputs from the gastrointestinal tract, liver, pancreas, adipose tissue and skeletal muscle, mediated by many different signalling molecules. Obesity occurs when control of energy intake is not matched by the degree of energy expenditure. Obesity is not only a state of disordered energy balance it is also characterized by systemic inflammation. Systemic inflammation is triggered by the leakage of bacterial lipopolysaccharide through changes in intestinal permeability. The endocannabinoid system, consisting of the cannabinoid receptors, endogenous cannabinoid ligands and their biosynthetic and degradative enzymes, plays vital roles in the control of energy balance, the control of intestinal permeability and immunity. In this review we will discuss how the endocannabinoid system, intestinal microbiota and the brain-gut axis are involved in the regulation of energy balance and the development of obesity-associated systemic inflammation. Through direct and indirect actions throughout the body, the endocannabinoid system controls the development of obesity and its inflammatory complications.

Citing Articles

Cannabidiol treatment improves metabolic profile and decreases hypothalamic inflammation caused by maternal obesity.

da Silva Rodrigues F, Jantsch J, de Farias Fraga G, Silva Dias V, Eller S, de Oliveira T Front Nutr. 2023; 10:1150189.

PMID: 36969815 PMC: 10033544. DOI: 10.3389/fnut.2023.1150189.


The Endocannabinoid System and Physical Exercise.

Matei D, Trofin D, Iordan D, Onu I, Condurache I, Ionite C Int J Mol Sci. 2023; 24(3).

PMID: 36768332 PMC: 9916354. DOI: 10.3390/ijms24031989.


L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation.

Kopustinskiene D, Masteikova R, Lazauskas R, Bernatoniene J Antioxidants (Basel). 2022; 11(4).

PMID: 35453344 PMC: 9030479. DOI: 10.3390/antiox11040660.


Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity.

DiPatrizio N Nutrients. 2021; 13(4).

PMID: 33916974 PMC: 8067588. DOI: 10.3390/nu13041214.


The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Romero-Zerbo S, Garcia-Fernandez M, Espinosa-Jimenez V, Pozo-Morales M, Escamilla-Sanchez A, Sanchez-Salido L Front Endocrinol (Lausanne). 2020; 11:103.

PMID: 32210914 PMC: 7067697. DOI: 10.3389/fendo.2020.00103.